Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
6
×
glaxosmithkline
6
×
life sciences
national blog main
national top stories
6
×
startups
6
×
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
deals
eli lilly
fda
alzheimer's disease
amgen
bristol-myers squibb
cancer immunotherapy
merck
abbvie
What
roundup
bio
black
companies
diamond’s
disease
nash
new
news
therapeutics
according
address
adds
ago
akcea
alliance
allosteric
appetite
approval
biogen’s
biopharmaceutical
biotech
bread
bristol
butter
buy
buyout
calls
cancer
cases
cash
centers
changing
cigarettes
clinic
color
continue
control
convo
crispr
Language
unset
Current search:
glaxosmithkline
×
startups
×
" national top stories "
×
" clinical trials "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More